Literature DB >> 4913865

The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.

D T Mason, J F Spann, R Zelis, E A Amsterdam.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 4913865     DOI： 10.1002/cpt1970114460

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.

Authors:  P H Hinderling; E R Garrett
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

2.  Controlled trial of prophylatic treatment with lidocaine in acute myocardial infarction.

Authors:  W Bleifeld; K W Merx; K W Heinrich; S Effert
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

3.  Antiarrhythmic agents. II. Therapeutic considerations.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 4.  Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Anaesthetic problems associated with the treatment of cardiovascular disease: I. Digitalis toxicity.

Authors:  D C Chung
Journal:  Can Anaesth Soc J       Date:  1981-01

6.  The effects of lidocaine on cardiac parasympathetic control in normal subjects and in subjects after myocardial infarction.

Authors:  S Abramovich-Sivan; Y Bitton; J Karin; D David; S Akselrod
Journal:  Clin Auton Res       Date:  1996-12       Impact factor: 4.435

7.  Bretylium tosylate in the management of refractory ventricular fibrillation.

Authors:  R W Dhurandhar; S J Teasdale; W A Mahon
Journal:  Can Med Assoc J       Date:  1971-07-24       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.